US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes
Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.